Pleurocidin Peptide Enhances Grouper Anti-Vibrio harveyi Immunity Elicited by Poly(lactide-co-glycolide)-Encapsulated Recombinant Glyceraldehyde-3-phosphate Dehydrogenase

被引:11
作者
Chuang, Shu-Chun [1 ]
Huang, Wan-Ling [2 ]
Kau, Sau-Wei [2 ]
Yang, Yun-Pei [2 ]
Yang, Chung-Da [2 ]
机构
[1] Kaohsiung Med Univ, Coll Med, Dept Physiol, Kaohsiung 807, Taiwan
[2] Natl Pingtung Univ Sci & Technol, Grad Inst Anim Vaccine Technol, 1,Shuefu Rd, Pingtung 912, Taiwan
关键词
Vibrio harveyi (V. harveyi); pleurocidin (PLE); glyceraldehyde-3-phosphate dehydrogenase (GAPDH); poly(lactide-co-glycolide) (PLG);
D O I
10.3390/vaccines2020380
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Outer membrane proteins, such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), are considered immunodominant antigens for eliciting protective immunity against Vibrio harveyi, the main etiological agent of vibriosis in fish. Cationic antimicrobial peptides (AMPs), such as pleurocidin (PLE), play important roles in activating and recruiting immune cells, thereby contributing to subsequent innate and adaptive immune responses. In the present study, we aimed to use PLE peptide as a potent adjuvant to improve the immunogenicity of V. harveyi recombinant GAPDH (rGAPDH). In order to prepare a controlled-release vaccine, PLE peptide and rGAPDH protein were simultaneously encapsulated into polymeric microparticles made from the biodegradable poly(lactide-co-glycolide) (PLG) polymer. The resulting PLG-encapsulated PLE plus rGAPDH (PLG-PLE/rGAPDH) microparticles, 3.21-6.27 mu m in diameter, showed 72%-83% entrapment efficiency and durably released both PLE and rGAPDH for a long 30-day period. Following peritoneal immunization in grouper (Epinephelus coioides), PLG-PLE/rGAPDH microparticles resulted in significantly higher (p < 0.05, nested design) long-lasting GAPDH-specific immunity (serum titers and lymphocyte proliferation) than PLG-encapsulated rGAPDH (PLG-rGAPDH) microparticles. After an experimental challenge of V. harveyi, PLG-PLE/rGAPDH microparticles conferred a high survival rate (85%), which was significantly higher (p < 0.05, chi-square test) than that induced by PLG-rGAPDH microparticles (67%). In conclusion, PLE peptide exhibits an efficacious adjuvant effect to elicit not only improved immunity, but also enhanced protection against V. harveyi in grouper induced by rGAPDH protein encapsulated in PLG microparticles.
引用
收藏
页码:380 / 396
页数:17
相关论文
共 31 条
[1]  
Harikrishnan R., Balasundaram C., Heo M.S., Diet enriched with mushroom Phellinus linteus extract enhances the growth, innate immune response, and disease resistance of kelp grouper, Epinephelus bruneus against vibriosis, Fish Shellfish Immunol., 30, pp. 128-134, (2011)
[2]  
Liu P.C., Lee K.K., Chen S.N., Susceptibility of different isolates of Vibrio harveyi to antibiotics, Microbios, 91, pp. 175-180, (1997)
[3]  
Sommerset I., Krossoy B., Biering E., Frost P., Vaccines for fish in aquaculture, Expert Rev. Vaccines, 4, pp. 89-101, (2005)
[4]  
Yu L.P., Hu Y.H., Sun B.G., Sun L., Immunological study of the outer membrane proteins of Vibrio harveyi: Insights that link immunoprotectivity to interference with bacterial infection, Fish Shellfish Immunol., 35, pp. 1293-1300, (2013)
[5]  
Ningqiu L., Junjie B., Shuqin W., Xiaozhe F., Haihua L., Xing Y., Cunbin S., An outer membrane protein, OmpK, is an effective vaccine candidate for Vibrio harveyi in Orange-spotted grouper (Epinephelus coioides), Fish Shellfish Immunol., 25, pp. 829-833, (2008)
[6]  
Zhang C., Yu L., Qian R., Characterization of OmpK, GAPDH and their fusion OmpK-GAPDH derived from Vibrio harveyi outer membrane proteins: Their immunoprotective ability against vibriosis in large yellow croaker (Pseudosciaena crocea), J. Appl. Microbiol., 103, pp. 1587-1599, (2007)
[7]  
Zhang C., Yu L., Qian R., Cloning and expression of Vibrio harveyi OmpK* and GAPDH* genes and their potential application as vaccines in large yellow croakers Pseudosciaena crocea, J. Aquat. Anim. Health, 20, pp. 1-11, (2008)
[8]  
Sirover M.A., On the functional diversity of glyceraldehyde-3-phosphate dehydrogenase: Biochemical mechanisms and regulatory control, Biochim. Biophys. Acta, 1810, pp. 741-751, (2011)
[9]  
Secombes C., Will advances in fish immunology change vaccination strategies?, Fish Shellfish Immunol., 25, pp. 409-416, (2008)
[10]  
Garlapati S., Facci M., Polewicz M., Strom S., Babiuk L.A., Mutwiri G., Hancock R.E., Elliott M.R., Gerdts V., Strategies to link innate and adaptive immunity when designing vaccine adjuvants, Vet. Immunol. Immunopathol., 128, pp. 184-191, (2009)